SEC Form 4 · accession 0001140361-16-046686
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jan 4, 2016 | S | 500 | $52.97 | D | 75,611 | I | Douglas Family Trust |
| ResMed Common Stock | Jan 4, 2016 | M | 5,837 | $19.25 | A | 81,448 | I | Douglas Family Trust |
| ResMed Common Stock | Jan 4, 2016 | S | 5,837 | $52.97 | D | 75,611 | I | Douglas Family Trust |
| ResMed Common Stock | holding | — | — | — | 31,304 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $19.25 | Jan 4, 2016 | M | 5,837 | D | Feb 3, 2007 | Feb 3, 2016 | ResMed Common Stock | 5,837 | 0 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable.